Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01828021
Title Phase 2 Study of the Monoclonal Antibody MGAH22(Margetuximab)in Patients With Relapsed or Refractory Advanced Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors MacroGenics
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94115 United States Details
Stanford University Stanford California 94305 United States Details
Florida Cancer Research Institute Plantation Florida 33324 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
Tufts Cancer Center Boston Massachusetts 02111 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from for the field